415
Views
3
CrossRef citations to date
0
Altmetric
Brief Communication

Dalbavancin for infective endocarditis: a single centre experience

ORCID Icon, , , , , & show all
Pages 256-262 | Received 12 Jun 2020, Accepted 09 Sep 2020, Published online: 19 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammad Said Ramadan, Raffaella Gallo, Marina Lugarà, Michele Gambardella, Gabriella Oliva, Lorenzo Bertolino, Roberto Andini, Nicola Coppola, Rosa Zampino & Emanuele Durante-Mangoni. (2022) Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review. Journal of Chemotherapy 34:6, pages 360-366.
Read now
Massimo Andreoni, Matteo Bassetti, Salvatore Corrao, Francesco Giuseppe De Rosa, Vincenzo Esposito, Marco Falcone, Paolo Grossi, Federico Pea, Nicola Petrosillo, Carlo Tascini, Mario Venditti & Pierluigi Viale. (2021) The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Review of Anti-infective Therapy 19:9, pages 1125-1134.
Read now

Articles from other publishers (1)

Matteo Bassetti, Laura Labate, Antonio Vena & Daniele R. Giacobbe. (2021) Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications. Current Opinion in Infectious Diseases 34:2, pages 96-108.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.